[VYNE] QoQ Quarter Result on 30-Jun-2019 [#Q2]

Stock
[VYNE] VYNE Therapeutics Inc.
Announcement Date
01-Aug-2019
Financial Year
2019
Quarter
30-Jun-2019 [#Q2]
Profit Trend
QoQ- 12.70%
YoY- -97.40%
Quarter Report
VYNE's Result
VYNE's Financial Summary
View:
Show?
Quarter Result
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
Revenue 1,750 0 0 0 0 -10,640 0 -
PBT -40,233 -21,498 -16,855 -16,477 -18,873 -17,594 -12,847 113.90%
Tax 728 -52,379 0 0 0 -11 0 -
NP -40,233 -21,498 -16,855 -16,477 -18,873 -17,594 -12,847 113.90%
Tax Rate - - - - - - - -
Total Cost 41,983 21,498 16,855 16,477 18,873 6,954 12,847 120.05%
Ratio Analysis
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
NP Margin -2,299.03 0.00 0.00 0.00 0.00 165.36 0.00 -
Per Share
31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 CAGR
EPS -68.15 -64.36 -50.66 -49.65 -58.35 -54.68 -40.26 41.98%
EPS Diluted -68.15 -64.36 -50.66 -49.65 -58.35 -54.68 -40.26 41.98%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.